Cargando…
Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows
In this randomized controlled trial on four commercial grazing dairy farms, we investigated whether pegbovigrastim (PEG) treatment affects clinical mastitis (CM) and uterine disease (i.e. retained placenta (RP), metritis and endometritis) occurrence during a full lactation. The association of prepar...
Autores principales: | Barca, Joaquín, Meikle, Ana, Bouman, Mette, Gnemmi, Giovanni, Ruiz, Rodrigo, Schukken, Ynte H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158865/ https://www.ncbi.nlm.nih.gov/pubmed/34043727 http://dx.doi.org/10.1371/journal.pone.0252418 |
Ejemplares similares
-
Increase in white blood cell counts by pegbovigrastim in primiparous and multiparous grazing dairy cows and the interaction with prepartum body condition score and non-esterified fatty acids concentration
por: Barca, Joaquín, et al.
Publicado: (2021) -
Effects of pathogen-specific clinical mastitis occurrence in the first 100 days of lactation 1 on future mastitis occurrence in Holstein dairy cows: An observational study
por: Hertl, Julia A., et al.
Publicado: (2023) -
Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
por: Denis-Robichaud, J., et al.
Publicado: (2021) -
Effect of Pegbovigrastim on Hematological Profile of Simmental Dairy Cows during the Transition Period
por: Trimboli, Francesca, et al.
Publicado: (2019) -
Molecular Epidemiology of Mastitis Pathogens of Dairy Cattle and Comparative Relevance to Humans
por: Zadoks, Ruth N., et al.
Publicado: (2011)